Yelena Janjigian, Chief of Gastrointestinal Oncology at Memorial Sloan Kettering Cancer Center, posted on LinkedIn:
“FGFR2B expression as a bookmaker in first line GEC.
Congratulations to all the investigators.”
Read Further: Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology.